US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Quasi-New Stocks

617.02

-1.8776-0.30%

Number of Gainers:48

Number of Losers:108

Number of Flat:13

PE:- -

High:619.76

Open:618.80

Low:605.24

Close:618.90

Loading ...

Zest AI Launches LuLu Strategy Module to Expand Generative AI to Financial Institutions

Dolly Varden Silver Expands Golden Triangle Holdings with Strategic Acquisition

Flora Growth Ventures into Cryptocurrency with Strategic Investments

Recursion Pharmaceuticals Shares Fall 3.9% Premarket After Q1 Results

THOMSON REUTERS

Janux Therapeutics Initiates Phase 1B Expansion Studies With Janx007 in Patients With Prostate Cancer and Provides Program Updates

THOMSON REUTERS

Janux Therapeutics Inc - Updates on Janx007 and Janx008 Expected in H2 2025

THOMSON REUTERS

Janux Therapeutics Initiates Phase 1b Expansion Studies with JANX007 in Patients with Prostate Cancer and Provides Program Updates

Analysts Offer Insights on Technology Companies: AppLovin (APP) and Super Micro Computer (SMCI)

Werewolf Therapeutics to Participate in Upcoming Investor Conferences

Is Janux Therapeutics, Inc. (JANX) the Best Small Cap Stock to Buy with the Biggest Upside Potential?

Figs Inc : Telsey Advisory Group Cuts Target Price to $5 From $7

THOMSON REUTERS

Palatin Presents Promising Preclinical Data for Melanocortin Agonist PL9588 at ARVO 2025, Highlighting a Dual-Action Glaucoma Therapy

FIGS Is Maintained at Market Perform by Telsey Advisory Group

Zevia PBC Is Maintained at Market Perform by Telsey Advisory Group

Angel Oak Mortgage REIT, Inc. Reports First Quarter 2025 Financial Results

THOMSON REUTERS

Angel Oak Mortgage Q1 Pretax Profit USD 20.531 Million

THOMSON REUTERS

Angel Oak Mortgage Q1 Dividend USD 0.32

THOMSON REUTERS

Angel Oak Mortgage Q1 EPS USD 0.87

THOMSON REUTERS

Angel Oak Mortgage Q1 Net Interest Income USD 10.087 Million

THOMSON REUTERS

Angel Oak Mortgage Q1 Net Income USD 20.5 Million

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4539/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4539","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","market":"US","secType":"PLATE","nameCN":"Quasi-New Stocks","latestPrice":617.0228,"timestamp":1746561599999,"preClose":618.90045,"halted":0,"volume":309023192,"delay":0,"changeRate":-0.003034,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-1.877625,"latestTime":"05-06 16:00:00 EDT","open":618.8015,"high":619.759,"low":605.2417,"amount":6882630227.152761,"amplitude":0.023457,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1746604800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.547806,"peRate":361.368422,"turnoverRate":0.023457,"increases":48,"decrements":108,"flats":11,"marketCap":433152270619.0625,"floatMarketCap":312322983178.875},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","high":619.759,"amplitude":0.023457,"preClose":618.90045,"low":605.2417,"pbRate":"5.547806","latestPrice":617.0228,"volume":309023192,"delay":0,"open":618.8015,"prevYearClose":648.26935,"prevWeekClose":626.7683,"prevMonthClose":599.1775,"prevQuarterClose":570.2879,"fiveDayClose":608.8738,"twentyDayClose":507.4442,"sixtyDayClose":741.3953,"secType":"PLATE","market":"US","turnoverRate":0.023457,"peRate":361.368422,"marketCap":433152270619.0625,"floatMarketCap":312322983178.875,"timestamp":1746561599999,"nameCN":"Quasi-New Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4539\",,,,undefined,":{"bkCode":"BK4539","up":48,"down":108,"flat":13},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4539\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2533538404","title":"Zest AI Launches LuLu Strategy Module to Expand Generative AI to Financial Institutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2533538404","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533538404?lang=en_us&edition=fundamental","pubTime":"2025-05-05 21:00","pubTimestamp":1746450000,"startTime":"0","endTime":"0","summary":"Latest module in the LuLu platform series available first to MeridianLink customers, empowering credit unions and banks with advanced lending intelligence. \"By equipping financial institutions with advanced generative AI tools like LuLu Strategy, we're not just helping individual organizations, we're strengthening the entire financial ecosystem by fostering greater innovation throughout the sector. Now, financial institutions have better insights to responsibly expand access to affordable credit to Main Street consumers, which strengthens the economy overall,\" said Mike de Vere, CEO of Zest AI. \"This partnership with MeridianLink allows us to scale our solution rapidly across the financial services landscape, empowering regional banks and credit unions with the same caliber of technology that was once the exclusive domain of national institutions.\". \"While generative AI adoption remains limited among the majority of financial institutions and lenders, LuLu bridges this technology gap, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/zest-ai-launches-lulu-strategy-130000450.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zest-ai-launches-lulu-strategy-130000450.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","BK4211","STRK","BK4596","BK4600","MLNK","BK4595","BK4539","BK4588","BK4023","FISI","BK4516"],"gpt_icon":1},{"id":"2533158132","title":"Dolly Varden Silver Expands Golden Triangle Holdings with Strategic Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2533158132","media":"TIPRANKS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533158132?lang=en_us&edition=fundamental","pubTime":"2025-05-05 20:37","pubTimestamp":1746448652,"startTime":"0","endTime":"0","summary":"Dolly Varden Silver ( ($TSE:DV) ) just unveiled an announcement. Dolly Varden Silver Corporation has announced a definitive agreement to acquire He...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/dolly-varden-silver-expands-golden-triangle-holdings-with-strategic-acquisition?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/dolly-varden-silver-expands-golden-triangle-holdings-with-strategic-acquisition?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","DV","BK4023"],"gpt_icon":0},{"id":"2533329581","title":"Flora Growth Ventures into Cryptocurrency with Strategic Investments","url":"https://stock-news.laohu8.com/highlight/detail?id=2533329581","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533329581?lang=en_us&edition=fundamental","pubTime":"2025-05-05 20:36","pubTimestamp":1746448574,"startTime":"0","endTime":"0","summary":"Flora Growth ( ($FLGC) ) has shared an announcement. Flora Growth Corp. has announced a strategic investment into the cryptocurrency and blockchain...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/flora-growth-ventures-into-cryptocurrency-with-strategic-investments?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/flora-growth-ventures-into-cryptocurrency-with-strategic-investments?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","FLGC","BK4183"],"gpt_icon":0},{"id":"2533589134","title":"Recursion Pharmaceuticals Shares Fall 3.9% Premarket After Q1 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2533589134","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533589134?lang=en_us&edition=fundamental","pubTime":"2025-05-05 20:32","pubTimestamp":1746448360,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nL4N3RD0QK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4548","BK4539","BK4609","BK4611","BK4139","RXRX"],"gpt_icon":0},{"id":"2533899345","title":"Janux Therapeutics Initiates Phase 1B Expansion Studies With Janx007 in Patients With Prostate Cancer and Provides Program Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2533899345","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533899345?lang=en_us&edition=fundamental","pubTime":"2025-05-05 20:30","pubTimestamp":1746448202,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nTUA4CML8Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["JANX","BK4539","BK4139"],"gpt_icon":0},{"id":"2533589931","title":"Janux Therapeutics Inc - Updates on Janx007 and Janx008 Expected in H2 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2533589931","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533589931?lang=en_us&edition=fundamental","pubTime":"2025-05-05 20:30","pubTimestamp":1746448202,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nTUA4CML8Y:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","JANX"],"gpt_icon":0},{"id":"2533535516","title":"Janux Therapeutics Initiates Phase 1b Expansion Studies with JANX007 in Patients with Prostate Cancer and Provides Program Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2533535516","media":"Business Wire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533535516?lang=en_us&edition=fundamental","pubTime":"2025-05-05 20:30","pubTimestamp":1746448200,"startTime":"0","endTime":"0","summary":"Phase 1b expansion study initiated in taxane-nave mCRPC patients. Updated data from Phase 1a dose escalation support initiation of Phase 1b dose expansion. Updates on JANX007 and JANX008 expected in the second half of 2025. Janux to host R&D Day in mid-2025 highlighting preclinical pipeline progression to the clinic. ENGAGER-PSMA-01 is a first-in-human, open-label, multicenter Phase 1 clinical trial designed to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary efficacy of JANX007 administered as monotherapy or in combination in adult patients with advanced metastatic castration-resistant prostate cancer .In December 2024, Janux reported positive interim clinical data from the Phase 1a dose escalation portion of the trial in 16 mCRPC patients with a median of four prior lines of therapy. At that time, the median radiographic progression-free survival  reported was 7.4 months for all 16 patients.* As of April 21, 2025, updated results** have been achi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/janux-therapeutics-initiates-phase-1b-123000756.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4539","LENZ","BK4139","BK4007","JANX"],"gpt_icon":0},{"id":"2533586578","title":"Analysts Offer Insights on Technology Companies: AppLovin (APP) and Super Micro Computer (SMCI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2533586578","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533586578?lang=en_us&edition=fundamental","pubTime":"2025-05-05 20:02","pubTimestamp":1746446530,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on AppLovin (APP – Research Report) and Super Micro Com...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-technology-companies-applovin-app-and-super-micro-computer-smci?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-technology-companies-applovin-app-and-super-micro-computer-smci?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU1861215975.USD","BK4613","BK4539","BK4023","LU1861220033.SGD","SMCI","LU0053671581.USD","BK4170","BK4608","APP","BK4588","BK4543"],"gpt_icon":0},{"id":"2533258971","title":"Werewolf Therapeutics to Participate in Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2533258971","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533258971?lang=en_us&edition=fundamental","pubTime":"2025-05-05 20:00","pubTimestamp":1746446400,"startTime":"0","endTime":"0","summary":"WATERTOWN, Mass., May 05, 2025  -- Werewolf Therapeutics, Inc.  , an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate the body’s immune system for the treatment of cancer and other immune-mediated conditions, today announced that management will participate in the following upcoming investor conferences in the month of May:. The Citizens Life Sciences Conference 2025Date: Thursday, May 8, 2025 Time: 10:00am ETLocation: New York Hilton Midtown Management will participate in a fireside chat. Bank of America Securities 2025 Health Care ConferenceDate: Wednesday, May 14, 2025 Time: 3:15pm PTLocation: The Encore Hotel, Las Vegas, NVManagement will participate in a fireside chat. WEREWOLF, the WEREWOLF logo, PREDATOR, INDUKINEand other Werewolf trademarks, service marks, graphics and logos are trade names, trademarks or registered trademarks of Werewolf Therapeutics, Inc., in the United States or other countries. ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/werewolf-therapeutics-participate-upcoming-investor-120000414.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","HOWL","LENZ","BK4539","BK4007"],"gpt_icon":0},{"id":"2533850035","title":"Is Janux Therapeutics, Inc. (JANX) the Best Small Cap Stock to Buy with the Biggest Upside Potential?","url":"https://stock-news.laohu8.com/highlight/detail?id=2533850035","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533850035?lang=en_us&edition=fundamental","pubTime":"2025-05-05 19:58","pubTimestamp":1746446306,"startTime":"0","endTime":"0","summary":"We recently published a list of Top 11 Small Cap Stocks to Buy with Biggest Upside Potential. In this article, we are going to take a look at where Janux Therapeutics, Inc.  stands against other top small cap stocks to buy with biggest upside potential.On April 24, Jill Carey Hall, BofA Securities head of U.S. small/mid-cap strategy, appeared on ‘Closing Bell’ to talk about the impact of tariffs on small caps. She also discussed the outlook for the category, saying that the earnings backdrop is essential. When we look back a year ago, investors were excited about small caps, as the earnings were recovering and the market was coming out of the 2023 earnings recession. Everyone expected that these stocks would see double-digit earnings growth by mid-last year, outpacing large caps. That got pushed out for over a year, and now the sector has sold off a lot.Therefore, she reasoned that she would stick with higher-quality stocks that are more profitable and have strong o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/janux-therapeutics-inc-janx-best-115826728.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4539","TQQQ","TSYW.SI","USJW.SI","PSQ","QID","SQQQ","USAW.SI","NQmain","QLD",".IXIC","JANX","MNQmain","BK4139","NVIW.SI"],"gpt_icon":1},{"id":"2533583136","title":"Figs Inc : Telsey Advisory Group Cuts Target Price to $5 From $7","url":"https://stock-news.laohu8.com/highlight/detail?id=2533583136","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533583136?lang=en_us&edition=fundamental","pubTime":"2025-05-05 19:32","pubTimestamp":1746444727,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nFWN3RD1Z8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1878469433.USD","FIGS","BK4539","BK4202","BK4198","BK4561","BK4535"],"gpt_icon":0},{"id":"2533658582","title":"Palatin Presents Promising Preclinical Data for Melanocortin Agonist PL9588 at ARVO 2025, Highlighting a Dual-Action Glaucoma Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2533658582","media":"PR Newswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533658582?lang=en_us&edition=fundamental","pubTime":"2025-05-05 19:30","pubTimestamp":1746444600,"startTime":"0","endTime":"0","summary":"Topical melanocortin therapy shows promise for treating glaucoma. PL9588 lowers intraocular pressure  by increasing aqueous outflow. Supports continued development of PL9588 as a novel, dual-action glaucoma therapy. CRANBURY, N.J., May 5, 2025 /PRNewswire/ --Palatin Technologies, Inc. , a biopharmaceutical company advancing innovative treatments targeting the melanocortin receptor system, today announced new preclinical data for PL9588, a novel melanocortin receptor agonist, presented at the 2025 Association for Research in Vision and Ophthalmology  Annual Meeting. The findings support the potential of PL9588 as a topical treatment for glaucoma, combining both IOP-lowering and neuroprotective effects.The poster, titled \"Activation of the Melanocortin System Increases Aqueous Outflow, Reduces Intraocular Pressure , and Protects Neurons in Glaucoma Models,\" was presented on May 4 by Dr. Alison Obr of Palatin. The full poster is available at www.palatin.com.\"Palatin is leading innovation ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/palatin-presents-promising-preclinical-data-113000210.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/palatin-presents-promising-preclinical-data-113000210.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4539","TM","MCR","03160","BK4555","BK4585","BK4588","BK4604","PTN","BK4139","BK4007","BK4099"],"gpt_icon":1},{"id":"2533588259","title":"FIGS Is Maintained at Market Perform by Telsey Advisory Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2533588259","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533588259?lang=en_us&edition=fundamental","pubTime":"2025-05-05 19:18","pubTimestamp":1746443880,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/FIGS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 05, 2025 07:18 ET (11:18 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","LU1878469433.USD","BK4539","FIGS","BK4202","BK4561","BK4198"],"gpt_icon":0},{"id":"2533588430","title":"Zevia PBC Is Maintained at Market Perform by Telsey Advisory Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2533588430","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533588430?lang=en_us&edition=fundamental","pubTime":"2025-05-05 19:16","pubTimestamp":1746443760,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ZVIA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 05, 2025 07:16 ET (11:16 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4177","BK4539","PBC","ZVIA"],"gpt_icon":0},{"id":"2533300453","title":"Angel Oak Mortgage REIT, Inc. Reports First Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2533300453","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533300453?lang=en_us&edition=fundamental","pubTime":"2025-05-05 19:00","pubTimestamp":1746442802,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nTUA5ZBZT6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AOMR","BK4539","BK4110"],"gpt_icon":0},{"id":"2533930046","title":"Angel Oak Mortgage Q1 Pretax Profit USD 20.531 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2533930046","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533930046?lang=en_us&edition=fundamental","pubTime":"2025-05-05 19:00","pubTimestamp":1746442801,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nPLXBBE942:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4110","AOMR"],"gpt_icon":0},{"id":"2533497300","title":"Angel Oak Mortgage Q1 Dividend USD 0.32","url":"https://stock-news.laohu8.com/highlight/detail?id=2533497300","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533497300?lang=en_us&edition=fundamental","pubTime":"2025-05-05 19:00","pubTimestamp":1746442801,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nPLXBBE942:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4110","AOMR","BK4539"],"gpt_icon":0},{"id":"2533300103","title":"Angel Oak Mortgage Q1 EPS USD 0.87","url":"https://stock-news.laohu8.com/highlight/detail?id=2533300103","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533300103?lang=en_us&edition=fundamental","pubTime":"2025-05-05 19:00","pubTimestamp":1746442801,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nPLXBBE942:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AOMR","BK4110","BK4539"],"gpt_icon":0},{"id":"2533004633","title":"Angel Oak Mortgage Q1 Net Interest Income USD 10.087 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2533004633","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533004633?lang=en_us&edition=fundamental","pubTime":"2025-05-05 19:00","pubTimestamp":1746442801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nPLXBBE942:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4110","BK4539","AOMR"],"gpt_icon":0},{"id":"2533004573","title":"Angel Oak Mortgage Q1 Net Income USD 20.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2533004573","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533004573?lang=en_us&edition=fundamental","pubTime":"2025-05-05 19:00","pubTimestamp":1746442801,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nPLXBBE942:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4110","AOMR","BK4539"],"gpt_icon":0}],"pageSize":20,"totalPage":39,"pageCount":7,"totalSize":774,"code":"91000000","status":"200"}]}}